Valuation : Bio-Rad Laboratories, Inc.

Market Cap 10.02B 8.62B 8.13B 7.41B 13.85B 958B 13.97B 96.83B 37.26B 486B 37.62B 36.8B 1,543B P/E 2026 *
45.3x
P/E 2027 * 44.3x
Enterprise Value 9.27B 7.97B 7.52B 6.85B 12.81B 886B 12.93B 89.59B 34.48B 450B 34.81B 34.05B 1,428B EV / Sales 2026 *
3.6x
EV / Sales 2027 * 3.44x
Free-Float
60.19%
Yield 2026 *
-
Yield 2027 * -
1 day-1.85%
1 week-4.61%
Current month-4.17%
1 month+4.36%
3 months+27.15%
6 months+38.14%
Current year+22.12%
1 week 369.33
Extreme 369.33
390.73
1 month 349.37
Extreme 349.37
396.23
Current year 236.73
Extreme 236.73
396.23
1 year 236.73
Extreme 236.73
396.23
3 years 211.43
Extreme 211.43
396.23
5 years 211.43
Extreme 211.43
821.65
10 years 154.7
Extreme 154.7
832.7
Manager TitleAgeSince
Chief Executive Officer 76 01/01/2003
President 61 09/09/2024
Director of Finance/CFO 55 15/04/2024
Director TitleAgeSince
Chairman 76 01/01/2012
Director/Board Member 73 25/04/2017
Director/Board Member 79 25/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Exercice

Chief Executive Officer

12,510 0.0577%
01/09/26 Exercice

EVP, President, LSG

1,004 0.0046%
01/09/26 Other

Chief Executive Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-2.22%-4.61%+33.62%+2.01% 10.02B
-1.41%-5.09%-20.18%+0.79% 182B
-1.16%-1.63%-0.80%+12.51% 118B
-0.71%-4.39%+8.80%+81.40% 61.7B
-0.32%-5.26%+12.44%+44.05% 50.55B
-1.89%-6.03%-6.43%-34.01% 48.98B
+0.75%-5.80%+11.20%-21.23% 31.65B
-4.90%-11.40% - - 29.87B
+2.25%+0.50%+34.96%-13.27% 23.71B
-1.46%-9.48%-14.50%+4.76% 21.78B
Average -1.02%-3.92%+6.57%+8.56% 57.79B
Weighted average by Cap. -1.10%-3.00%-3.12%+11.56%

Financials

2026 *2027 *
Net sales 2.57B 2.21B 2.09B 1.9B 3.56B 246B 3.59B 24.87B 9.57B 125B 9.66B 9.45B 396B 2.63B 2.26B 2.14B 1.95B 3.64B 252B 3.67B 25.45B 9.79B 128B 9.89B 9.67B 406B
Net income 225M 193M 182M 166M 311M 21.5B 314M 2.17B 836M 10.9B 844M 826M 34.63B 230M 198M 186M 170M 317M 21.96B 320M 2.22B 854M 11.14B 863M 844M 35.38B
Net Debt -749M -644M -608M -554M -1.04B -71.61B -1.04B -7.24B -2.79B -36.32B -2.81B -2.75B -115B -965M -830M -783M -714M -1.33B -92.3B -1.35B -9.33B -3.59B -46.82B -3.63B -3.55B -149B
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
10/09/26 $370.18 -1.80% 178,824
09/09/26 $376.97 -0.83% 177,000
08/09/26 $380.12 -1.55% 138,843
04/09/26 $386.11 -0.46% 112,950
03/09/26 $387.90 -0.16% 148,027
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
376.97USD
Average target price
329.00USD
Spread / Average Target
-12.73%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!